Zosano Pharma Corporation

The pandemic renewed interest in vaccines, and with Pfizer Inc. and Moderna, Inc. making mRNA vaccines a reality, and a hugely commercially successful one at that, more vaccine companies are in th

Clovis Oncology has warned it is “increasingly probable” that it will enter bankruptcy as revenues shrink and the regulatory outlook worsens for its only marketed drug, Rubraca. The Bolder, CO-based

The US FDA issued decisions on two new drug applications combining an on-body infusion device and an established drug last week. While the decisions went different ways – Supernus Pharmaceuticals, In

Bogged down by an ongoing spat with its largest shareholder and a share price that continues to flirt with penny stock territory, Mereo BioPharma Group plc announced an updated operating plan on 18